Featured Research

from universities, journals, and other organizations

Cancer vaccine impact limited unless drug industry focuses on difficult-to-treat tumors, experts say

Date:
November 21, 2011
Source:
University of Michigan Health System
Summary:
Drug companies currently developing therapeutic cancer vaccines may be determining the cancers they target based on the number of annual cases, not the number of deaths they cause. This approach may limit the patient benefits of such drugs, according to a new University of Michigan report.

Drug companies currently developing therapeutic cancer vaccines may be determining the cancers they target based on the number of annual cases, not the number of deaths they cause.

Related Articles


This approach may limit the patient benefits of such drugs, according to a new University of Michigan report.

Therapeutic vaccines, an alternative form of cancer treatment that may be more effective than traditional cancer therapies, are currently being tested in clinical trials around the world.

Early studies on these vaccines, which trigger patients' immune systems to attack cancer cells, have shown they may offer new hope for those suffering from difficult-to-treat cancers.

"In 2011, there were about 230 clinical trials for therapeutic vaccines targeting 13 different types of cancer," says Matthew Davis, M.D., M.A.P.P., associate professor of pediatrics, internal medicine, and public policy at the University of Michigan Health System and Gerald R. Ford School of Public Policy.

"If a cancer is more commonly diagnosed in the United States, it is significantly more likely to have therapeutic vaccines in clinical trials," Davis adds. "Focusing on annual incidence is a very common approach by drug companies in developing new therapies."

Therapeutic vaccine development should focus on cancers with higher mortality rates, creating more potential to improve patient outcomes, Davis suggests.

"The lack of a connection between therapeutic cancer vaccine development and cancer deaths means that vaccine development in this arena today may not best serve the needs of cancer patients tomorrow," Davis says. "As a primary care doctor, I would like to see innovations with therapeutic vaccines that target cancers where our current therapies are less effective than average."

Davis and co-author Elias Dayoub, a second-year medical student, emphasize that lung cancer and pancreatic cancer are two tumor types where the five-year survival is lower than average and the number of patients newly diagnosed each year is higher than average.

"Fortunately for patients, there are already some late-stage clinical trials in progress for patients with cancers of the lung and pancreas," Davis says. "Based on the typical time course for trials and licensure, if these vaccines are safe and effective, we may able to use them to help patients as early as 2020 and perhaps earlier."

The cancers with the highest number of active clinical trials in 2011 are melanoma (40), breast (34), lung (30), prostate (22), and brain (20).

The five cancers with the highest five-year mortality (estimated by the authors, based on current U.S. data) are lung (186,000), pancreas (40,000), colon (35,000), breast (21,000) and liver and bile duct (21,000), for a total of 303,000 deaths. There are currently 90 therapeutic vaccines in development against these 5 types of cancer.

In contrast, the five cancers with the most active development (146 vaccines in aggregate) target cancers with a lower five-year mortality of approximately 226,000. "This mismatch is unfortunate for patients," says Davis. "Cancers with higher mortality currently have fewer vaccines in development. For therapeutic vaccines to make the biggest difference in cancer care, development must focus more on high-mortality tumors."


Story Source:

The above story is based on materials provided by University of Michigan Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Elias J. Dayoub and Matthew M. Davis. Relationship of therapeutic cancer vaccine development to population disease burden and five-year survival. Human Vaccines, Volume 7, Issue 11; November 2011; Pages 1124 - 1129 [link]

Cite This Page:

University of Michigan Health System. "Cancer vaccine impact limited unless drug industry focuses on difficult-to-treat tumors, experts say." ScienceDaily. ScienceDaily, 21 November 2011. <www.sciencedaily.com/releases/2011/11/111121142556.htm>.
University of Michigan Health System. (2011, November 21). Cancer vaccine impact limited unless drug industry focuses on difficult-to-treat tumors, experts say. ScienceDaily. Retrieved December 18, 2014 from www.sciencedaily.com/releases/2011/11/111121142556.htm
University of Michigan Health System. "Cancer vaccine impact limited unless drug industry focuses on difficult-to-treat tumors, experts say." ScienceDaily. www.sciencedaily.com/releases/2011/11/111121142556.htm (accessed December 18, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, December 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

AFP (Dec. 17, 2014) Border closures, quarantines and crop losses in West African nations battling the Ebola virus could lead to as many as one million people going hungry, UN food agencies said on Wednesday. Duration: 00:52 Video provided by AFP
Powered by NewsLook.com
When You Lose Weight, This Is Where The Fat Goes

When You Lose Weight, This Is Where The Fat Goes

Newsy (Dec. 17, 2014) Can fat disappear into thin air? New research finds that during weight loss, over 80 percent of a person's fat molecules escape through the lungs. Video provided by Newsy
Powered by NewsLook.com
Why Your Boss Should Let You Sleep In

Why Your Boss Should Let You Sleep In

Newsy (Dec. 17, 2014) According to research out of the University of Pennsylvania, waking up for work is the biggest factor that causes Americans to lose sleep. Video provided by Newsy
Powered by NewsLook.com
Flu Outbreak Closing Schools in Ohio

Flu Outbreak Closing Schools in Ohio

AP (Dec. 17, 2014) A wave of flu illnesses has forced some Ohio schools to shut down over the past week. State officials confirmed one pediatric flu-related death, a 15-year-old girl in southern Ohio. (Dec. 17) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins